Moderna: Speed Of COVID-19 Vaccine Now Hinges On Enrolling The Right Patients

 
• By Sarah Karlin-Smith
Conceptual hand writing showing Enroll. Business photo text officially register as member of institution or student on course
Moderna is proactively working to ensure it recruits a diverse patient base that will hit clinical outcomes for its Phase III vaccine trial • Source: Shutterstock

More from Vaccines

More from Pink Sheet